Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Change in Working Capital
Dexcom Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Change in Working Capital
-$29.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-22%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Change in Working Capital
$170m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Change in Working Capital
-$989m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Change in Working Capital
-$950m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Change in Working Capital
-$2.5B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Change in Working Capital
-$1.1B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
See Also
What is Dexcom Inc's Change in Working Capital?
Change in Working Capital
-29.3m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Change in Working Capital amounts to -29.3m USD.
What is Dexcom Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-22%
The average annual Change in Working Capital growth rates for Dexcom Inc have been 13% over the past three years , 8% over the past five years , and -22% over the past ten years .